UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD Anderson

Leukemia, 2014-02, Vol.28 (2), p.289-292

2014

Volltextzugriff (PDF)

A prognostic score for patients with lower risk myelodysplastic syndrome

Leukemia, 2008-03, Vol.22 (3), p.538-543

2008

Volltextzugriff (PDF)

Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation

Leukemia, 2013-04, Vol.27 (4), p.836-842

2013

Volltextzugriff (PDF)

Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia

Leukemia, 2014-07, Vol.28 (7), p.1543-1545

2014

Volltextzugriff (PDF)

The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience

Leukemia, 2014-04, Vol.28 (4), p.973-975

2014

Volltextzugriff (PDF)

A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission

Leukemia, 2012-11, Vol.26 (11), p.2428-2431

2012

Volltextzugriff (PDF)

Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML

Leukemia, 2013-10, Vol.27 (10), p.2081-2083

2013

Volltextzugriff (PDF)

The JAK-STAT pathway: a therapeutic target in hematological malignancies

Current cancer drug targets, 2006-12, Vol.6 (8), p.671-679

2006

Volltextzugriff (PDF)

Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution

Leukemia, 2009-12, Vol.23 (12), p.2275-2280

2009

Volltextzugriff (PDF)

Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia

Blood, 2003-10, Vol.102 (7), p.2379-2386

2003

Volltextzugriff (PDF)

Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndrome

Leukemia, 2016-02, Vol.30 (2), p.325-330

2016

Volltextzugriff (PDF)

Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome

Bone marrow transplantation (Basingstoke), 2009-06, Vol.43 (11), p.839-843

2009

Volltextzugriff (PDF)

P515: LOWER‐INTENSITY CPX‐351 + VENETOCLAX FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA WHO ARE UNFIT FOR INTENSIVE CHEMOTHERAPY

HemaSphere, 2022-06, Vol.6, p.414-415

2022

Volltextzugriff (PDF)

P514: V‐FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX‐351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3‐MUTATED ACUTE MYELOID LEUKEMIA

HemaSphere, 2022-06, Vol.6, p.413-414

2022

Volltextzugriff (PDF)

FIVE-YEAR FINAL RESULTS OF A PHASE 3 STUDY OF CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK/SECONDARY ACUTE MYELOID LEUKEMIA (AML)

Hematology, Transfusion and Cell Therapy, 2020-11, Vol.42, p.152-152

2020

Volltextzugriff (PDF)

Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia

Investigational new drugs, 2012-06, Vol.30 (3), p.1107-1115

2012

Volltextzugriff (PDF)

Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome

Leukemia, 2009-07, Vol.23 (7), p.1297-1302

2009

Volltextzugriff (PDF)

Treatment of B-cell chronic lymphocytic leukemia with nonchemotherapeutic agents: experience with single-agent and combination therapy

Leukemia, 2009-03, Vol.23 (3), p.457-466

2009

Volltextzugriff (PDF)

The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy

Leukemia & lymphoma, 2007-01, Vol.48 (10), p.1931-1939

2007

Volltextzugriff (PDF)

Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients with Refractory Multiple Myeloma

Clinical cancer research, 2004-01, Vol.10 (1), p.88-95

2004

Volltextzugriff (PDF)

Novel therapies for myelodysplastic syndromes

Cancer, 2004-07, Vol.101 (2), p.226-241

2004

Volltextzugriff (PDF)

Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy

Leukemia, 2003-06, Vol.17 (6), p.1100-1103

2003

Volltextzugriff (PDF)

Acute Leukemias

2nd Edition 2021, 2020

Volltextzugriff (PDF)

Leukemias: Principles and Practice of Therapy

1, 2010

Volltextzugriff (PDF)

Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia

OncoTargets and therapy, 2017-01, Vol.10, p.1413-1422

2017

Volltextzugriff (PDF)

1 – 25 von 1.121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.053)
Mit Volltextzugriff
(1.070)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(447)
Life Sciences & Biomedicine
(419)
Humans
(390)
Middle Aged
(304)
Oncology
(292)
Aged
(275)
Female
(253)
Adult
(251)
Biological And Medical Sciences
(251)
Male
(251)
Medical Sciences
(251)
Hematology
(229)
Hematologic And Hematopoietic Diseases
(188)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(185)
Aged, 80 And Over
(158)
Treatment Outcome
(148)
Prognosis
(120)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(103)
Adolescent
(97)
Tumors
(95)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD Anderson

A prognostic score for patients with lower risk myelodysplastic syndrome

Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation

Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia

The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience

A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission

Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML

The JAK-STAT pathway: a therapeutic target in hematological malignancies

Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution

Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia

Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndrome

Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome

P515: LOWER‐INTENSITY CPX‐351 + VENETOCLAX FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA WHO ARE UNFIT FOR INTENSIVE CHEMOTHERAPY

P514: V‐FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX‐351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3‐MUTATED ACUTE MYELOID LEUKEMIA

FIVE-YEAR FINAL RESULTS OF A PHASE 3 STUDY OF CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK/SECONDARY ACUTE MYELOID LEUKEMIA (AML)

Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia

Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome

Treatment of B-cell chronic lymphocytic leukemia with nonchemotherapeutic agents: experience with single-agent and combination therapy

The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy

Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients with Refractory Multiple Myeloma

Novel therapies for myelodysplastic syndromes

Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy

Acute Leukemias

Leukemias: Principles and Practice of Therapy

Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia

Suchergebnisse filtern